New Study Throws Into Question Long-Held Belief About

New Study Throws Into Question Long-Held Belief About Depression

Michael Bernstein, American Chemical Society New evidence puts into doubt the long-standing belief that a deficiency in serotonin — a chemical messenger in the brain — plays a central role in depression. In the journal ACS Chemical...

Latest Antidepressant Stories

2014-08-26 08:31:43

--Study to Utilize Sequential Parallel Comparison Design to Minimize Placebo Response, Same Design Utilized in AVP-923 Phase II Study in Agitation in Alzheimer's Disease-- ALISO VIEJO, Calif., Aug. 26, 2014 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the enrollment of the first patient into a phase II study to evaluate the efficacy, safety and tolerability of AVP-786 for the adjunctive treatment of major depressive disorder (MDD). AVP-786 is a novel...

2014-08-20 08:28:43

NEW YORK, Aug. 20, 2014 /PRNewswire/ -- Employers, law enforcement officers and physicians are among those who need reliable testing results to make informed decisions, driving demand for test technologies. In 2013, sales for drugs of abuse testing and technologies reached $2.8 billion, increasing 4.3% from 2011, according to Kalorama Information. A major contributing factor to growth is the continued growth of illicit drug use worldwide and the emergence of new drugs of abuse....

Premiere Of Universal Pictures "Man Of the Year" - Arrivals
2014-08-19 05:17:09

Rayshell Clapper for redOrbit.com - Your Universe Online On August 11, 2014, people were rocked by the news that Robin Williams had committed suicide by asphyxiation. He hung himself according to one CNN article. For many, the shock was too confusing. Williams helped the world through his stage performances, shows, and movies. He did charity work, entertained the troops, and spread laughter to many. His sudden suicide hurt many. A Huffington Post report included a written statement from...

parkinsons dopamine
2014-08-18 15:08:09

Lee-Ann Donegan, Penn Medicine Study Examined Patients Over First Two Years of Treatment New Penn Medicine research shows that neuropsychiatric symptoms such as depression, anxiety and fatigue are more common in newly diagnosed Parkinson’s disease (PD) patients compared to the general population. The study also found that initiation of dopamine replacement therapy, the most common treatment for PD, was associated with increasing frequency of impulse control disorders and excessive...

2014-08-13 12:28:00

Despite Expanding Generic Availability, Opportunity Remains for New Therapies, Particularly for Treatment-Resistant Depression, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 13, 2014 /PRNewswire/ -- Decision Resources Group finds that in the unipolar depression* market, the expanding use of two recently approved therapies--Lundbeck/Takeda Pharmaceutical's Brintellix (vortioxetine), Actavis (formerly Forest Laboratories)/Pierre Fabre's Fetzima (levomilnacipran...

2014-08-11 23:07:45

Zoloft Birth Defect Lawsuits Filed Allege SSRI Antidepressant Caused Children to Be Born with Various Congenital Malformations, Including Atrial Septal Defect; Persistent Pulmonary Hypertension of the Newborn, Neural Tube Defects, and Craniofacial Defects Reports Wright & Schulte LLC Columbus, OH (PRWEB) August 11, 2014 Wright & Schulte LLC, a nationally-recognized law firm representing plaintiffs in Zoloft lawsuits, notes that 13 new claims were recently filed in West Virginia...

2014-07-30 08:32:46

WOODCLIFF LAKE, N.J. and SAN DIEGO, July 30, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that an article based on post-hoc analyses from the three pivotal Phase 3 trials of lorcaserin entitled, "Early Weight Loss While on Lorcaserin, Diet, and Exercise as a Predictor of Week 52 Weight-Loss Outcomes," was recently published in the online issue of Obesity, the official peer reviewed journal of The Obesity Society. The objective of these...

depression stimulation
2014-07-23 02:00:16

Elsevier B.V. Brain stimulation treatments, like electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS), are often effective for the treatment of depression. Like antidepressant medications, however, they typically have a delayed onset. For example, a patient may receive several weeks of regular ECT treatments before a full response is achieved. Thus, there is an impetus to develop antidepressant treatments that act to rapidly improve mood. Low field magnetic...

2014-07-21 10:08:09

Wolters Kluwer Health Study shows increased use of treatment and screening recommendations after three-step initiative A performance improvement initiative for physicians can significantly increase their use of evidence-based practices in screening for and treating depression, in the July Journal of Psychiatric Practice. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. Led by Dr Michael E. Thase of the University of Pennsylvania Medical...

2014-07-15 16:27:44

LONDON, July 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023https://www.reportbuyer.com/product/2166742/Pristiq-Major-Depressive-Disorder---Forecast-and-Market-Analysis-to-2023.htmlPristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023SummaryMajor depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded...

Word of the Day
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'